International Journal of Virology and Molecular Biology

p-ISSN: 2163-2219    e-ISSN: 2163-2227

2017;  6(1): 9-23

doi:10.5923/j.ijvmb.20170601.02

 

Monitoring and Evaluation of Cytomegalovirus Detection and Risk Factors in Pregnant Women from Egypt

Ahmed R. Sofy 1, Khalid A. El-Dougdoug 2, Adel A. Mousa 1, Mahmoud R. Sofy 1, Ahmed A. Hmed 1, Ahmed A. Abbas 1

1Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt

2Virology Lab., Agric. Microbiology Department, Faculty of Agriculture, Ain Shams University, Cairo, Egypt

Correspondence to: Ahmed R. Sofy , Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt.

Email:

Copyright © 2017 The Author(s). Published by Scientific & Academic Publishing.

This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/

Abstract

Cytomegalovirus (CMV) is a β herpes virus with double-stranded DNA. Worldwide the current infective rate ranges between 40% and 100%. Fetal loss and abortion are responsible for significant emotional distress for couples desiring children. There are many documents which support the role of Cytomegalovirus (CMV) in spontaneous abortion. A total of one hundred and sixty-five (165) serum samples of pregnant women with anti-CMV IgG positive and with a definite diagnosis of previous abortion were determined. The detection of CMV was done using three methods, rapid chromatographic immunoassay, Enzyme-linked immunosorbent assays (ELISA), and real-time polymerase chain reaction (rt-PCR). The relation between age, time of the abortion, number of abortion, number of delivery, life style, blood transfusion, use of corticosteroids, gynecologic and medical history of abortion, residence and socioeconomic status, against CMV as risk factors of cases were studied. It was found that the best method for detection of CMV was rt-PCR (158/165) positive (96%), then ELISA was (132/165) positive (80%), and the last method rapid test was (99/165) positive (60%), All these methods useful in detection for treatment. Significant positive correlation between PCR, patients ages, number of abortion. While, the negative correlation between PCR and time of the abortion, number of delivery, use of corticosteroids, blood transfusion and life style were found.

Keywords: CMV, ELISA, rt-PCR, Virus, Risk factors, Abortion, Pregnant women, Egypt

Cite this paper: Ahmed R. Sofy , Khalid A. El-Dougdoug , Adel A. Mousa , Mahmoud R. Sofy , Ahmed A. Hmed , Ahmed A. Abbas , Monitoring and Evaluation of Cytomegalovirus Detection and Risk Factors in Pregnant Women from Egypt, International Journal of Virology and Molecular Biology, Vol. 6 No. 1, 2017, pp. 9-23. doi: 10.5923/j.ijvmb.20170601.02.

1. Introduction

Cytomegalovirus (CMV) was isolated for the first time in 1956 [1]. Weller gave the virus its name from the cytopathic effect produced in cell culture, where the virus causing these cytomegalic cells with intranuclear inclusions was isolated, and hence named Cytomegalovirus [2]. It is a member of the Herpesviridae family, where a β herpes virus with double-stranded DNA [3]. Worldwide the current infective rate ranges between 40% and 100% [4]. One of the previous studies shows that an IgG avidity assay could be used in combination with an IgM ELISA for monitoring pregnant women for primary CMV Infection [5]. While Enzyme-linked immunosorbent assay (ELISA) is one of the best methods for detecting CMV in pregnant women with right diagnoses and treatment [6]. CMV is one of the major causes of congenital infections. Its clinical manifestations range from asymptomatic forms (90% of cases) to severe fetal damage and, in rare cases, death due to abortion. Furthermore, 10%–15% of the children who are asymptomatic at birth may develop late squeal, especially hearing defects, after a period of months or even years [7]. The risk of fetal damage is higher if the primary infection occurs during the first trimester of pregnancy [8, 9]. The prevalence of congenital infection ranges from 0.2% to 2.5% in different populations [10, 11]. Furthermore, the prevalence of congenital infection varies with the prevalence of the infection in the population [12]. As well as increasing with age, may also depend on sexual activity and occupation, particularly occupations involving close contacts with children in a community setting. In the case of parents, contact with the urine or saliva of their children is a major source of infection [13, 14]. The risk of acquiring an infection during pregnancy is 0.7–1.38 % [15].
It is important to evaluate the risk to the pregnant women of being infected and/or symptomatically affected by CMV to provide appropriate counseling and guidance to infection control. So, the aim of this study was to assess for the major causes of CMV among pregnant women at higher risk of getting CMV.

2. Subjects and Methods

One hundred and sixty-five patients' pregnant women (PW) with repeated abortion happened more than once before. Five ml whole blood obtained under aseptic conditions from each subject by a vein puncture using a disposable syringe. The blood samples divided into two tubes, where the first tube contained EDTA for viral DNA isolation. While the second tube for the serum which was obtained by putting the blood samples in a clean dry plain plastic tube and was allowed to clot at 37ºC for 30 minutes before centrifugation. The tubes centrifuged at 4000 rpm for 5 minutes, and the supernatant (serum) was taken for serology and other tests. A structured interview using a standard maternal questionnaire administered by trained interviewers with the women at their first visit. Questions were asked about the following: age, time of apportion, number of apportion, number of delivery, life style, blood transfusion, use of corticosteroids, gynecologic and medical history of abortion, residence and socioeconomic status. All cases were diagnosed as CMV IgG positive using Rapid Chromatographic Immunoassay Test (RCIT) and Enzyme-linked immune sorbent assays (ELISA) for CMV antigen in the collected serum blood samples according to van der et al. [16] and Nielsen et al. [17], respectively. The ELISA technique performed using kits intended for estimating the concentration of specific CMV-IgM and CMV-IgG markers. The kits were purchased from Sigma Diagnostics (USA), the techniques were performed according to the manufacturer’s instructions. On the other hand, Helicobacter pylori (H. Pylori) assay was done by ELISA using the kits supplied by Diagnostic Products Corporation, USA.
Also, CMV was detected by a quantitative real-time PCR. DNA was extracted from samples (first tube) using a Qiagen kit (Qiagen, Valencia, CA, USA) and quantified using the standard laboratory protocol recommended by the manufacturer’s instructions. Qualitative real-time PCR reactions were carried out by using a light Cycler H Instrument (Roche Diagnostics, Meylan, France) with the QuantiTect Probe PCR Kit (Qiagen). Taqman probe (6FAM-CGCGAGACCGTGGAACTGCG-TAMRA), forward primer (5′GCAGCCACGGGATCGTACT-3′) and reverse primer (5′GGCTTTTACCTCACACGAGCATT-3′) were used for amplification according to Coisel et al. [18]. The reaction was carried out in 20 mL, in a final volume containing 10 mL of QuantiTect master mix, 0.2 mM of probe, 0.2 mM of each primer, and 4 mL of DNA. The PCR was initiated by an enzyme-activation incubation at 95 °C for 15 min to activate DNA Polymerase, followed by 40 cycles of denaturation at 95 °C for 10 s and an annealing-extension step at 60 °C for 1 min. Serial dilutions, ranging from 102 to 105 copies/ml of synthesized sequences that correspond to the targeted viral genes, were used as positive controls. These dilutions were also used to determine the viral load in positive samples. A CMV negative specimen was used as a negative control sample was considered positive by real-time PCR if it crossed the threshold.
Statistical Data Analysis: For assessment of risk factors for CMV infection (exposure), characteristics of case patients and control subjects examined using a two-sample Student t-test. Cross-tabulation and chi-square or Fisher exact tests were used to examine the relationship between variables using a 95% confidence interval as a measure of association. The sample size was calculated according to Raosoft, and all statistical calculations were done using SPSS (statistical package for the social science version 20.00) statistical program at 0.05 level of probability [19].

3. Results

This case-control study included 165 female patients. Their ages ranged from 20 to 41 years (mean of 26.37±0.34 SE). Their time of abortion, number of abortion and number of delivery ranged from 1 to 3, 0-2 and 0-3, respectively (mean of 2.16±0.06, 1.19±0.03 and 1.042±0.05, respectively). In addition, 70 patient’s village of life style representing 42.4% of female patients and 95 female city of life style representing 47.6% of females patients, 67 females were use of corticosteroids representing 40.6% and 98 females don’t use of corticosteroids representing 59.4% and 27 females exposed to blood transfusion representing 16.4% and 138 females were not exposed to blood transfusion representing 83.6% as shown in table (1).
Table 1. Descriptive clinical data of patients
     
The results obtained from the serological methods, RCIT and ELISA diagnosis as CMV IgG positive for CMV antigen in serum. The rapid test showed 99 patients were positive for IgM (60%), and 66 patients were negative for IgM (40%) (Table 2). On the other hand, ELISA showed 132 patients were positive for IgM (80%), and 33 patients were negative for IgM (20%) (Table 2). On the other hand, the results for the RT- PCR showed 158 out of 165 (96%) miscarriage women were found to be CMV positive, while 7 out of 165 (4%) patients were found CMV negative as shown in the table (2).
Table 2. Summary of evaluation of serological and molecular efficiency for CMV detection in pregnant women
     
The statistical highly significant difference was detected between the studied groups regarding age (years), time of abortion, number of abortion and number of delivery (P-value=0.000) as shown in the table (3) and figures (1, 2, 3 & 4).
Table 3. Comparison between life style regarding their demographic data
     
Figure (1). Box plot of groups as regards age and their statistical difference
Figure (2). Comparison between both groups as a time of abortion and their statistical significance
Figure (3). Comparison between both groups as a number of abortion and their statistical significance
Figure (4). Comparison between both groups as a number of delivery and their statistical significance
Haemoglobin (Hb) and white blood cells (WBCs) levels showed a highly significant increase in Village life style patients that mean ± SE 9.46±0.17, 3.70±0.12 respectively when compared with city life style patients that mean ± SE 10.58± 0.09, 4.79±0.10 (P-value = 0.000) as shown in table (4), and figures (5 and 6).
Table (4). Comparison between Life style as regard Haemoglobin (Hb) (g/dl) and WBCs (cu.mm)
     
Figure (5). Comparison between both groups as Hb (g/dl) and their statistical significance
Figure (6). Comparison between both groups as WBCs and their statistical significance
PCR and ELISA levels showed a highly significant decrease in village life style patients that mean ± SE 671.46±22.47, 0.65±0.02 respectively when compared with city life style that mean ± SE 450.73± 14.79, 0.42±0.02 (P-value = 0.000) as shown in the table (5), and figures (7 and 8). On the other hand, there was statistically highly significant difference (P-value=0.000) between village and city life style as regards rapid chromatographic immunoassay as shown in the previous table and figure (9).
Table (5). Comparison between Life style as regard PCR and ELISA
     
Figure (7). Comparison between both groups as PCR and their statistical significance
Figure (8). Comparison between both groups as ELISA and their statistical significance
Figure (9). Comparison between both groups as rapid chromatographic Immunoassay
There was no statistically significant difference (P-value=0.247) between village and city life style as regards birth defect (P-value=0.247) as shown in the table (6), and figure (10). On the other hand, there was statistically highly significant difference (P-value=0.000) between village and city life style as regards the use of corticosteroids, blood transfusion, as shown in the table (6), and figures (11 and 12).
Table (6). Comparison between life style in female patient regarding the birth defect, use of corticosteroids, blood transfusion
     
Figure (10). Comparison between both groups as a birth defect and their statistical significance
Figure (11). Comparison between both groups as Use of corticosteroids and their statistical significance
Figure (12). Comparison between both groups as Blood Transfusion and their statistical significance
Statistical highly significant difference was detected between the studied groups regarding age (years) that mean ± SE 28.66±0.52, 24.81±0.39, when compared with Use of corticosteroids, Time of abortion that mean ± SE 1.43±0.08, 2.65±0.05 when compared with Use of corticosteroids, number of abortion that mean ± SE 1.45±0.06, 1.01±0.02, when compared with Use of corticosteroids and number of delivery that mean ± SE 0.75±0.09, 1.24±0.06 when compared with Use of corticosteroids, (P-value=0.000) as shown in table (7), and figures (13, 14, 15 and 16).
Table (7). Comparison between the use of corticosteroids regarding their demographic data
     
Figure (13). Box plot of groups as regards age and their statistical difference
Figure (14). Comparison between both groups as a time of abortion and their statistical significance
Figure (15). Comparison between both groups as a number of abortion and their statistical significance
Figure (16). Comparison between both groups as a number of delivery and their statistical significance
PCR and ELISA levels showed a highly significant decrease in the use of corticosteroids patients that mean ± SE 729.88±20.07, 0.71±0.02 respectively when compared with don’t Use of corticosteroids that mean ± SE 417.54±8.54, 0.39±0.01 (P-value=0.000) as shown in the table (8) and figures (17 and 18).
Table (8). Comparison between Use of corticosteroids as regard PCR and ELISA
     
Figure (17). Comparison between both groups as PCR and their statistical significance
Figure (18). Comparison between both groups as ELISA and their statistical significance
Statistical highly significant difference was detected between the studied groups blood transfusion regarding age (years) that mean ± SE 31.48±0.67, 25.38±0.33 respectively when compared with don’t blood transfusion, time of abortion that mean ± SE 1.04±0.04, 2.38±0.06 when compared with don’t blood transfusion, number of abortion that mean ± SE 1.89±0.06, 1.05±0.02, when compared with don’t blood transfusion, and number of delivery that mean ± SE 0.41±0.14, 1.17±0.05 when compared with don’t blood transfusion (P-value=0.000) as shown in table (9), and figures (19, 20, 21, and 22).
Table (9). Comparison between blood transfusion regarding their demographic data
     
Figure (19). Box plot of groups as regards age and their statistical difference
Figure (20). Comparison between both groups as a time of abortion and their statistical significance
Figure (21). Comparison between both groups as a number of abortion and their statistical significance
Figure (22). Comparison between both groups as a number of delivery and their statistical significance
PCR and ELISA levels showed a highly significant decrease in blood transfusion patients that mean ± SE 867.92±14.45, 0.85±0.02 respectively when compared with don’t blood transfusion that mean ± SE 481.06±12.23, 0.45±0.01 (P-value = 0.000) as shown in the table (10), and figures (23 and 24). As well as, there was statistically highly significant difference (P-value=0.000) between use or not use of blood transfusion as regards Rapid chromatographic immunoassay as shown in the previous table and figure (25).
Table (10). Comparison between blood transfusion as regard PCR, ELISA, and Rapid chromatographic Immunoassay
     
Figure (23). Comparison between both groups as PCR and their statistical significance
Figure (24). Comparison between both groups as ELISA and their statistical significance
Figure (25). Comparison between both groups as rapid chromatographic Immunoassay and their statistical significance
PCR and ELISA levels showed a highly significant effect in positive rapid chromatographic immunoassay patients that mean ± SE 662.09±17.12, 0.65±0.02 respectively when compared with a negative rapid chromatographic immunoassay that mean ± SE 367.79± 4.37, 0.33±0.01 (P-value = 0.000) as shown in the table (11) and figures (26 and 27).
Table (11). Comparison between rapid chromatographic Immunoassay as regard PCR and ELISA
     
Figure (26). Comparison between both groups as PCR and their statistical significance
Figure (27). Comparison between both groups as ELISA and their statistical significance
The obtained results showed a statistically significant positive correlation between PCR, age patients, number of abortion, and. While the negative correlation between PCR, time of abortion, number of delivery, use of corticosteroids, blood transfusion and life style, (Table 12), and figures (28, 29, 30, 31, 32, 33, and 34).
Table (12). Correlation between PCR in relation to age patients, time of the abortion, number of abortion, number of delivery, use of corticosteroids, blood transfusion, birth defect and life style
     
Figure (28). Linear correlation between PCR, age and their statistical significance
Figure (29). Linear correlation between PCR, time of abortion and their statistical significance
Figure (30). Linear correlation between PCR, number of abortion and their statistical significance
Figure (31). Linear correlation between PCR, use of corticosteroids and their statistical significance
Figure (32). Linear correlation between PCR, number of delivery and their statistical significance
Figure (33). Linear correlation between PCR, blood transfusion and their statistical significance
Figure (34). Linear correlation between PCR, life style, and their statistical significance
As well as, the results showed a statistically significant negative correlation between PCR, Hb, WBCs, as shown in table (13), and figures (35 and 36).
Table (13). Correlation between PCR in relation to Hb (g/dl), WBCs (cu.mm)
     
Figure (35). Linear correlation between PCR, Hb and their statistical significance
Figure (36). Linear correlation between PCR, WBCs and their statistical significance
In addition, the obtained results showed a statistically significant positive correlation co-infection between (H. pylori and CMV), PCR, ELISA, as shown in the table (14), and figures (37 and 38).
Table (14). Correlation between H. pylori in relation to PCR, ELISA
     
Figure (37). Linear correlation between H. pylori, PCR, and their statistical significance
Figure (38). Linear correlation between H. pylori, ELISA, and their statistical significance

4. Discussion

CMV infection was much higher than other intrauterine infections like congenital toxoplasmosis (1%) and congenital rubella infection (2.7%) [20]. Primary CMV infection in an individual can be detected by demonstration of CMV specific IgM antibody [21].
CMV infection may be increased indirect effects caused by many risk factors which assumed to be associated with CMV among patients’ pregnant woman (PW) with repeated abortion. The evidence for association of CMV with these conditions is based on epidemiologic findings that show an increased risk for the infection.
From the obtained results, qPCR was more efficient in detection of CMV as (96%), than ELISA (80%), while rapid chromatographic immunoassay test was (60%). The rapid test CMV card is a rapid chromatographic immunoassay for the qualitative detection of CMV antigen in the sample to aid in the diagnosis of CMV infection (IgG, IgM) [22]. As well as, many previous studies showed that, an IgG avidity assay could be used in combination with an IgM ELISA for monitoring pregnant women for primary CMV Infection [5, 23].
Diagnosis of primary infection during pregnancy is a major task of the diagnostic virology laboratory. The diagnosis of primary infection is documented the appearance of virus-specific IgG in the serum of a pregnant woman who was previously seronegative. IgM detection in a pregnant woman is likely to be a reliable marker of primary infection; as it can reveal various clinical situations as related with the acute phase of primary infection, the convalescent phase of primary infection or persistence of IgM antibody [5, 23]. Enzyme-linked immunosorbent assays (ELISAs) have been more widely used in both the indirect and the capture ELISA format, with either labeled antigen or antibody. The indirect ELISA shows the following potential sources of error when performed on whole serum [24]. The mothers of who were positive IgM antibodies although all were positive for IgG antibodies, indicating primary infection in the past or reactivation/reinfection with a different strain of CMV in early pregnancy [25].
Our results also confirmed data of previous studies from Egypt and other Middle Eastern countries [26-29]. In a study from Iran by Bagheri et al. [26], the majority of pregnant women (72.1%) were positive for CMV IgG, and 2.5% were positive for CMV IgM. In Gaza strip, Palestine [30], the anti-CMV IgM was 6% among pregnant females, whereas in Turkey, the positivity for anti-CMV IgG antibody was 97.3%, while 1% were positive for anti-CMV IgM [31]. CMV total IgG antibodies were found in 92.1% in Saudi Arabia [27].
As well as, real-time PCR was a rapid, sensitive and useful technique for active diagnosis disease and monitoring response to therapy [32]. From the current study, PCR and ELISA levels showed a highly significant increase in village life style patients when compared with city life style (P-value=0.000). The statistical highly significant difference was detected between the studied groups regarding age (years), time of abortion and number of delivery when compared with the use of corticosteroids (P-value=0.000). The highly significant increase of patients means that use of corticosteroids than means of patients don’t use. On the other hand, PCR and ELISA levels showed a highly significant decrease in the use of corticosteroids patients when compared with don’t use of corticosteroids (P-value=0.000). As well as, our results showed that, PCR and ELISA levels showed a highly significant decrease in blood transfusion patients when compared with don’t blood transfusion (P-value=0.000). Also, the obtained results showed statistically highly significant difference was detected between the studied groups blood transfusion regarding age (years) when compared with don’t blood transfusion as well as, time of abortion, number of abortion and number of delivery (P-value=0.000). A statistically significant positive correlation between PCR, age patients, number of abortion, Hb, WBCs, ELISA. While there was a negative correlation between PCR and time of abortion, Rapid chromatographic Immunoassay, number of delivery, use of corticosteroids, blood transfusion, H. pylori and life style. These trends of results are in consistency with Khudhur et al. [33], they detected CMV in 151 (70%) of the 214 abortion women by IgG and IgM antibody. According to the age of patients, no difference was seen in results. Also, Pouria et al. [34], Munro et al. [35] and Arabpour et al. [36] got same results, while Shams et al. [37] noticed that, there is a difference between results according to patients age. In a study by Al-Kazaz et al. [38], CMV detection by ELISA found 46 positive to IgG out of 46 and 40 positive to IgM out of 46. Ramadhan and Jihad [39] reported that miscarriage women were the highest percentage of seropositive to CMV for IgG (40%) and (25%) for IgM out of 40 samples. Yasir [40] showed higher of IgG positive at age (27-32), and also Sotoodeh [41] showed 94% of positive IgG at age (25-34).
Previous studies showed that the primary CMV infection during pregnancy appears to be a much greater risk factor for congenital CMV infection than recurrent infections. Among infants born to women with primary infections during pregnancy, 32.3% had congenital CMV infection. In contrast, among infants born to pregnant women with recurrent CMV infections, 1.4% had congenital infection. The studies of pregnant women with possible primary infection all used IgM as a marker for primary infection in IgG-positive women. It has since been shown that women who have been IgG positive for a long time can be positive for IgM [42, 43], suggesting that IgM is also a marker for recurrent infection.
Risk factors for CMV infection have been correlated with the socioeconomic status within a community [44, 45]. Other studies showed that elderly persons seem to be well protected against symptomatic CMV disease due to the accumulation of CD28 effector cytotoxic T lymphocytes. This is a characteristic feature of all age groups but is most pronounced in elderly persons [46].
In consistency with our findings, Shams et al. [37] found that from 327 pregnant women 54 were anti CMV positive. Anti-CMV was detected in 94% of the women who had abortion history. Edmunds et al. [47] conducted their study on 130 (aborted women, suspected men, and pregnant women) could detect positive IgM to 70 patient and positive IgG to 97 patients. The prevalence rates of human cytomegalovirus IgM and IgG in non-pregnant women have been reported to be 1% and 84% respectively, and 2.5% and 90% in pregnant women [48]. Khalf et al. [49] detected positive IgM to CMV in 15.7% of 108 pregnant women. Also, Mahdi et al. [50] reported that, an increase in seropositive CMV-IgG in relation to abortion and infection. As a consequence of placental infection, CMV impairs cytotrophoblast differentiation and invasiveness; this could explain early abortion occurring in women with primary infection.
In this study, all samples with positive results for IgG could be attributable to many factors one of these factors, the majority of women of childbearing age are seropositive for CMV and that they contract the infection either through prenatal or postnatal transmission during early childhood and these trends of results are in matching with findings by Ali et al. [51]. Another factor is the poor of living conditions and hygienic practices, which facilitates that, CMV is easily transmitted by many routes; sexual and non-sexual routes [52].
Risk factors for CMV infection have been correlated with the socioeconomic status within the community [45]. In addition, the ELISA result seropositivity of all the cases mention before, showed there is a significant association between recurrent abortion, premature delivery and intrauterine death and cytomegalovirus infections. A hypothesis for the probable role of geographical influence upon CMV seroprevalence might be the route of infection. In rural areas, saliva is probably the main route through which the virus is transmitted postnatally. This is likely to be the route through which the virus is transmitted early in life amongst infants and young children due to poor sanitation [53].
On the other hand, in urban areas sexual transmission seems to be the major route of infection later in life during childbearing age. Another factor that may contribute to human CMV infection prevalence is geographical distribution [54-56]. Moreover, primary infections rate was higher throughout urban areas [57]. In the present study, CMV specific IgM antibody was detected in (15.7%) of all pregnant women tested indicating the substantial prevalence of infection in the local population. Our result is higher than the result reported by Alwan [48]; (46.6%), this difference may be due to small sample size for their study.
Also, the results obtained by the current study was in a positive relationship with the results of Ione et al. [58]. In regards with geographical distribution, our study exhibited that, the prevalence of seropositivity for CMV was higher than western Europe, America, and Australia [35]. However, our result is higher than the result of other studies that reported CMV specific IgM antibody in (12.9%) of pregnant women with complication [59].
As well as, our findings support the association between H. pylori and CMV infection. It is difficult to understand the exact mechanism for H. pylori activation in pregnancy. Previous studies that investigated this relationship [60, 61]. Lanciers et al. [62] have also found that pregnancy may be associated with increased susceptibility to H. pylori infection. Possible explanations for this could be an altered gastric pH as a result of altered fluid dynamics in pregnancy, which may result in the activation of a latent H. pylori infection; also, altered humoral and cell-mediated immunity during pregnancy, as well as changes in the various classes of antibodies during different gestational periods, could lead to H. pylori activation. All these hypotheses might explain increased seropositivity for H. pylori during pregnancy and may associate with other infection including CMV.

5. Conclusions

Our findings indicate that, CMV infection is a common in our local population and rt-PCR is the best diagnostic tool for the diagnose as well as, ELISA which considered as a sufficient method in most cases. this high seroprevalence reflects the low hygienic standards and practices on our part. Also, CMV can lead to substantial damage to the fetus and as the damage done in utero cannot be reverted, control of intrauterine CMV infection is important. Hence, prevention of CMV infection, is essential by a screening of pregnant women, to reduce the fatal outcome of the pregnancy occurring due to the CMV infection. So, we recommend pregnant women should be attentive to disease prevention guidelines on personal hygiene during pregnancy, especially hand washing after handling diapers or oral secretions. But we recommend high risk pregnant women for example mothers that use corticosteroid or after blood transfusion and rural communities should be screened for CMV serological test during pregnancy. All pregnant women, especially with bad obstetric history, should be screened for the presence of CMV infections as well as, screening against other maternal infection to exclude any congenital infection such as (S TO R CH) is mandatory. These risk factors suggest that interventions might be most efficient if they are targeted toward certain groups.

References

[1]  Smith MG (1956). Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SVG) disease. Proc Soc Exp Biol Med, 92: 424–430.
[2]  Craig JM, Macauley JC, Weller TH and Wirth P (1957). Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc Soc Exp Biol Med, 94: 4-12.
[3]  Crough T and Khanna R (2009). Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev, 22: 76-98.
[4]  Yi F, Zhao J, Luckheeram RV, Lei Y, Wang C, Huang S, et al. (2013). The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China. Virology Journal, 10: 43.
[5]  Chakravarti A, Kashyap B and Wadhwa A (2007). Relationship of IgG avidity index and IgM levels for the differential diagnosis of primary from recurrent cytomegalovirus infections. Iran J Allergy Asthma Immunol, 6: 197-201.
[6]  Lequin RM (2005). Enzyme immunoassay (EIA)/ enzyme-linked immunosorbent assay (ELISA). Clin Chem, 51(12): 2415–2418.
[7]  Stagno S and Whitley RJ (1985). Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med, 313(20): 1270-2174.
[8]  Stagno S, Pass RF and Cloud G (1986). Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. Journal of the American Medical Association, 256(14): 1904–1908.
[9]  Adler SP and Marshall B (2007). Cytomegalovirus infections. Pediatrics in Review, 28(3): 92–100.
[10]  Demmler GJ (1991). Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis, 13: 315-329.
[11]  Barbi M, Binda S, Primache V and Clerici D (1998). Congenital cytomegalovirus infection in a northern Italian region. European Journal of Epidemiology, 14(8): 791–796.
[12]  Malm G and Engman ML (2007). Congenital cytomegalovirus infections. Seminars in Fetal and Neonatal Medicine, 12(3): 154–159.
[13]  Pass RF, Hutto C, Ricks R and Cloud GA (1986). Increased rate of cytomegalovirus infection among parents of children attending day-care centers. The New England Journal of Medicine, 314(22): 1414–1418.
[14]  Fowler KB and Pass RF (2006). Risk factors for congenital cytomegalovirus infection in the offspring of young women: exposure to young children and recent onset of sexual activity. Pediatrics, 118: e286-e292.
[15]  Staras SAS, Dollard SC, Radford KW, Flanders WD, Pass RF and Cannon MJ (2006). Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clinical Infectious Diseases, 43(9): 1143–1151.
[16]  van der Bij W, Schirm J, Torensma R, van Son WJ, Tegzess AM and The TH (1988). Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol, 26(12): 2531-2535.
[17]  Nielsen SL, Sorensen I and Andersen HK (1988). Kinetics of specific immunoglobulins M, E, A, and G in congenital, primary, and secondary cytomegalovirus infection studied by antibody-capture enzyme-linked immunosorbent assay. J Clin Microbiol, 26(4): 654–661.
[18]  Coisel Y, Bousbia S, Forel JM, Hraiech S, Lascola B, Roch A, et al. (2012). Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia. PLoS One, 7(12): e51340.
[19]  Snedecor GW and Chochran WG (1982). Statistical Methods. 7th ed. Iowa State Univ Press, Iowa, USA.
[20]  Wong A, Tank KH, Tee CS and Yeo GS (2000). Seroprevalence of cytomegalovirus, toxoplasma and parvovirus in pregnancy. Singapore Med J, 41(4): 151-155.
[21]  Balasubramanium V, Simmrah M, Tan DS, Redzwan G and Loman SG (1994). The role of cytomegalovirus (CMV) infection in congenital diseases in Malaysia. Med J Malaysia, 49(2): 113-116.
[22]  Afifi SS, Zaki AS, Mohamed FA and El Hosseiny H (2009). Isolation and Identification of Non-Polio Enteroviruses from children in different Egyptian governorates. Australian Journal of Basic and Applied Sciences, 3(4): 3230-3238.
[23]  Revello MG and Gerna G (2002). Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev, 15(4): 680-715.
[24]  Kamel N, Metwally L, Gomaa N, Sayed Ahmed WA, Lotfi M and Younis S (2014). Primary cytomegalovirus infection in pregnant Egyptian women confirmed by cytomegalovirus IgG avidity testing. Med Princ Pract, 23(1): 29-33.
[25]  Gandhoke I, Aggarwal R, Lal S and Khare S (2006). Congenital CMV infection in symptomatic infants in Delhi and surrounding areas. Indian J Pediatr, 73: 1095-1097.
[26]  Bagheri L, Mokhtarian H, Sarshar N and Ghahramani M (2012). Seroepidemiology of cytomegalovirus infection during pregnancy in Gonabad, east of Iran: a cross-sectional study. J Res Health Sci, 12(1): 38–44.
[27]  Ghazi HO, Telmesani AM and Mahomed MF (2002). TORCH agents in pregnant Saudi women. Med Princ Pract, 11(4): 180–182.
[28]  Shaamash AH, Mohamed IS, Hasan MA and Ibrahim MA (2003). Preconceptional immunity to cytomegalovirus and the risk of symptomatic congenital infection. Int J Gynaecol Obstet, 83(2): 199–201.
[29]  Kafi S, Eldouma E, Saeed S and Musa H (2009). Seroprevalence of Cytomegalovirus among blood donors and antenatal women attending two hospitals in Khartoum State. Sudan Journal of Medical Sciences, 4(4): 1–5.
[30]  Al-Hindi A, Al-Helou T and Al-Helou Y (2010). Seroprevalence of Toxoplasma gondii, cytomegalovirus, rubella virus and Chlamydia trachomatis among infertile women attending in vitro fertilization center, Gaza strip, Palestine. J Egypt Soc Parasitol, 40(2): 451–458.
[31]  Uyar Y, Balci A, Akcali A and Cabar C (2008). Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey. New Microbiol, 31(4): 451–455.
[32]  Prince HE and Leber AL (2002). Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels. Clin Diagn Lab Immunol, 9(4): 824-827.
[33]  Khudhur AS, Di Zenzo G, and Carrozzo M, (2014). Oral lichenoid tissue reactions: diagnosis and classification. Expert Rev Mol Diagn, 14(2): 169–184.
[34]  Pouria S, State OI, Wong W and Hendry BM (1998). CMV infection is associated with transplant renal artery stenosis. Q J Med, 91: 185-189.
[35]  Munro SC, Hall B, Whybin LR, Leader L, Robertson P, Maine GT and Rawlinson WD (2005). Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol, 43(9): 4713-4718.
[36]  Arabpour M, Kaviyonee K, Jankash A and Yoghobi R (2007). Human cytomegalovirus infection in women of child bearing age throughout Fars Province-Iran: a population-based cohort study. Malaysian J Microbial, 3(2): 23-28.
[37]  Shams A, Sultan A, Sanaullah K, Shahid N, Irum G, Sobia A, et al. (2011). Prevalence and detection of cytomegalovirus by polymerase chain reaction (PCR) and simple ELISA in pregnant women. African Journal of Biotechnology, 10(34): 6616-6619.
[38]  Al-Kazaz L, Abdul Kareem A, Esraa A, Mohammed A and Bilal K (2014). Quantitative Detection of Human Cytomegalovirus DNA in pregnant women in Iraq using Real – time PCR., Current Research in Microbiology and Biotechnology, 2(1): 298-300.
[39]  Ramadhan RS and Jihad SA (2015). Molecular study of CMV isolated from women with repeated miscarriage in relation to immune response molecule TLR2. International Journal of Advanced Research, 3(6): 725-732.
[40]  Yasir S (2012). Detection of human Cytomegalovirus infection in spontaneous miscarriage and infertility. University of Kufa, College medicine. PhD thesis.
[41]  Sotoodeh A, Jaromil J and Jarhrom M (2009). Seropositivity for cytomegalovirus in women with spontaneous abortion. PhD Thesis University of Medical Science, Bander Abbas. Iran.
[42]  Schoub BD, Johnson S, McAnerney JM, Blackburn NK, Guidozzi F, Ballot D, Rothberg A (1993). Is antenatal screening for rubella and cytomegalovirus justified? S Afr Med J, 83(2): 108–110.
[43]  Stagno S, Tinker MK, Elrod C, Fuccillo DA, Cloud G and O'Beirne AJ (1985). Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants. J Clin Microbiol, 21(6): 930–935.
[44]  Fowler KB, Stagno S and Pass RF (1993). Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J Infect Dis, 168(3): 552-556.
[45]  Fowler KB, Stagno S and Pass RF (2003). Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA, 289(8): 1008-1011.
[46]  Pedron B, Guerin V, Jacquemard F, Munier A, Daffos F, Thulliez P, Aujard Y, Luton D and Sterkers G (2007). Comparison of CD8+ T Cell responses to cytomegalovirus between human fetuses and their transmitter mothers. J Infect Dis, 196: 1033-1043.
[47]  Edmunds WJ, Gay NJ, Kretzschmar M and Wachmann H (2000). The pre-vaccination epidemiology of measles, mumps and rubella in Europe: Implications for modelling studies. Epidemiol Infect, 125(3): 635-650.
[48]  Alwan A (2011). Sera interleukin-10, and interlukin-12 level among Iraqi aborted women infected with human cytomegalovirus. Higher Diploma thesis. Health and Medical Tachnical College. Foundation of Technical Education.
[49]  Khalf MS, Ahmad DW and Ibraheem KA (2012). The Seroprevalence of IgM among Iraqi Aborted Women Infected with Human Cytomegalovirus, The Iraqi Post Graduate Medical Journal, 11(1): 123-129.
[50]  Mahdi BM, Saour MY and Salih WH (2011). Cytomegalovirus infection in fertile women. J Exp Integr Med, 1(4): 273-276.
[51]  Ali HYM, Yaseen SA and Najem SN (1992). Prevalence of cytomegalovirus infection in child bearing age women in Mosul. Jord Med L, 26: 53-58.
[52]  Jahromi AS, Makiani MJ, Farjam MR, Madani A, Amirian M, Eftekhri TE and Hamidipour S (2010). Cytomegalovirus Immunity in Pregnancy in South of Iran. Am J Infect Dis 6(1): 8-12.
[53]  Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM and Galama JM (2002). Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv, 57(4): 245-56.
[54]  Wen L, Wu S and Lu S (1996). The epidemiological study on human cytomegalovirus infection of pregnant women and the maternal-fetal transmission in three Chinese metropolis. Zhonghua Fu Chan Ke Za Zhi, 31(12): 714-717.
[55]  Gratacap-Cavallier B, Bosson JL, Morand P, Dutertre N, Chanzy B, Jouk PS, et al. (1998). Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur J Epidemiol, 14(2): 147-152.
[56]  Mustakangas P, Sarna S, Ammälä P, Muttilainen M, Koskela P and Koskiniemi M (2000). Human cytomegalovirus seroprevalence in three socioeconomically different urban areas during the first trimester: a population-based cohort study. Int J Epidemiol, 29(3): 587-591.
[57]  Forbes BA (1998). Acquisition of cytomegalovirus infection: an update. Clin Microbiol Rev, 2(2): 204-216.
[58]  Ione R, Fomda BA, Thokar M, Wani T, Kakru D, Shaheen R, et al. (2004). Seroprevalence of cytomegalovirus (CMV) in Kashmir valley- A preliminary study. JK Practitioner, 11(4): 261-262.
[59]  Kapil A and Baroor S (1992). Cytomegalovirus Infection in pregnant and non pregnant women in India. Ind J Med Microbio, 10: 53-55.
[60]  Shaban MM, Kandil HO and Elshafei AH (2014). Helicobacter pylori seropositivity in patients with hyperemesis gravidarum. Am J Med Sci, 347(2): 101-105.
[61]  Frigo P, Lang C, Reisenberger K, Kölbl H and Hirschl AM. (1998). Hyperemesis gravidarum associated with Helicobacter pylori seropositivity. Obstet Gynecol, 91(4): 615-617.
[62]  Lanciers S, Despinasse B, Mehta DI and Blecker U. (1999). Increased susceptibility to Helicobacter pylori infection in pregnancy. Infect Dis Obstet Gynecol, 7(4): 195-198.